The Role of Propolis in Oxidative Stress and Lipid Metabolism: A Randomized Controlled Trial

Abstract EN

Although there is evidence of the benefits of propolis on human health, the vast majority of studies have been conducted using animal models.

The present study includes the chemical characterization and clinical evaluation of the effects of the oral administration of propolis solution on the oxidative status and modulation of lipids in a human population in Talca, Chile.

Chemical characterization of propolis, total phenol, flavonoids, and total antioxidant capacity were determined by ORAC.

Identification of phenols and flavonoids in propolis was assessed by HPLC-DAD.

A double-blind, placebo-controlled clinical trial was conducted.

Subjects provided informed consent form and the Bioethics Committee of the Universidad de Talca approved protocol.

Eligible subjects (n=67) were randomized in two groups: propolis (n=35) and placebo (n=32).

All subjects were evaluated at 0 (baseline), 45, and 90 days.

In the propolis group, we observed that increases in HDL-c went from 53.9 ± 11.9 to 65.8 ± 16.7 mg/dL (p<0.001) from baseline to 90 days.

Compared to placebo subjects, consumption of propolis induced a net increase in GSH levels (p<0.0001) and a decrease (p<0.001) in TBARS levels for the propolis group.

Our findings indicate potential benefits of propolis use in human health.

The use of propolis appears to have positive effects on oxidative status and improvement of HDL-c, both of which contribute to a reduced risk of cardiovascular disease.